240
Participants
Start Date
November 30, 2004
Primary Completion Date
February 28, 2009
Study Completion Date
February 28, 2009
PROMETRIUM® 300 mg
300 mg (3x100mg capsules) by mouth once daily at bedtime for 10 days X 3 cycles
PROMETRIUM® 400 mg
400 mg (4x100mg capsules) by mouth once daily at bedtime for 10 days X 3 cycles
Site 29, Mobile
Site 41, Montgomery
Site 26, Tucson
Site 5, Jonesboro
Site 39, Carmichael
Site 17, Encinitas
Site 10, San Diego
Site 42, Avon
Site 3, Groton
Site 22, New Britian
Site 9, Waterbury
Site 37, West Hartford
Site 14, Aventura
Site 40, Clearwater
Site 1, West Palm Beach
Site 30, West Palm Beach
Site 46, Atlanta
Site 43, Powder Springs
Site 36, Champaign
Site 12, Chicago
Site 6, Baton Rouge
Site 7, Baltimore
Site 2, St Louis
Site 16, Reno
Site 45, New York
Site 23, New Bern
Site 15, Winston-Salem
Site 28, Winston-Salem
Site 33, Cincinnati
Site 32, Erie
Site 47, Hershey
Site 44, Philadelphia
Site 38, Pottstown
Site 13, Greenville
Site 8, Conroe
Site 11, Corpus Christi
Site 27, Houston
Site 34, Houston
Site 24, San Antonio
Site 35, Salt Lake City
Site 19, Norfolk
Site 4, Seattle
Solvay Pharmaceuticals
INDUSTRY